Naresha Saligrama

Naresha Saligrama

Auto-generated profile, based on publicly available information

Naresha Saligrama

Department of Microbiology and Immunology, Stanford University , Stanford CA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2020 in Nature
Verified
Journal Article
Closed access
PDF file
DGDavid Gate
David Gate
NSNaresha Saligrama
Naresha Saligrama
OLOlivia Leventhal
Olivia Leventhal
AYAndrew C. Yang
Andrew C. Yang
MUMichael Unger
Michael Unger
TWTony Wyss-Coray
Tony Wyss-Coray

3 July 2019 in Nature
Verified
Journal Article
Closed access
PDF file
BDBen W. Dulken
Ben W. Dulken
MBMatthew T. Buckley
Matthew T. Buckley
PNPaloma Navarro Negredo
Paloma Navarro Negredo
NSNaresha Saligrama
Naresha Saligrama
RCRomain Cayrol
Romain Cayrol
ABAnne Brunet
Anne Brunet

15 April 2022 in Science
Verified
Journal Article
Open access
JLJing Li
Jing Li
MZMaxim Zaslavsky
Maxim Zaslavsky
YSYapeng Su
Yapeng Su
JGJing Guo
Jing Guo
MSMichael J. Sikora
Michael J. Sikora
MDMark M Davis
Mark M Davis
In this work, we find that CD8 + T cells expressing inhibitory killer cell immunoglobulin-like receptors (KIRs) are the human equivalent of Ly49 + CD8 + regulatory T cells in mice and are increased in the blood and inflamed tissues of patients with a variety of autoimmune diseases. Moreover, these CD8 + T cells efficiently eliminated pathogenic gliadin-specific CD4 + T cells from the leukocytes of celiac disease patients in vitro. We also find elevated levels of KIR + CD8 + T cells, but not CD4 + regulatory T cells, in COVID-19 patients, correlating with disease severity and vasculitis. Selective ablation of Ly49 + CD8 + T cells in virus-infected mice led to autoimmunity after infection. Our results indicate that in both species, these regulatory CD8 + T cells act specifically to suppress pathogenic T cells in autoimmune and infectious diseases.

7 August 2019 in Nature
Verified
Journal Article
Closed access
PDF file
NSNaresha Saligrama
Naresha Saligrama
FZFan Zhao
Fan Zhao
MSMichael J. Sikora
Michael J. Sikora
WSWilliam S. Serratelli
William S. Serratelli
RFRicardo A. Fernandes
Ricardo A. Fernandes
MDMark M Davis
Mark M Davis

22 September 2011 in Blood
Verified
Journal Article
Closed access
PDF file
RNRajkumar Noubade
Rajkumar Noubade
DKDimitry N. Krementsov
Dimitry N. Krementsov
RRRoxana del Rio
Roxana del Rio
TTTina Thornton
Tina Thornton
VNViswas Nagaleekar
Viswas Nagaleekar
CTCory Teuscher
Cory Teuscher
Although several transcription factors have been shown to be critical for the induction and maintenance of IL-17 expression by CD4 Th cells, less is known about the role of nontranscriptional mechanisms. Here we show that the p38 MAPK signaling pathway is essential for in vitro and in vivo IL-17 production by regulating IL-17 synthesis in CD4 T cells through the activation of the eukaryotic translation initiation factor 4E/MAPK-interacting kinase (eIF-4E/MNK) pathway. We also show that p38 MAPK activation is required for the development and progression of both chronic and relapsing-remitting forms of experimental allergic encephalomyelitis (EAE), the principal autoimmune model of multiple sclerosis. Furthermore, we show that regulation of p38 MAPK activity specifically in T cells is sufficient to modulate EAE severity. Thus, mechanisms other than the regulation of gene expression also contribute to Th17 cell effector functions and, potentially, to the pathogenesis of other Th17 cell–mediated diseases.

25 June 2013 in Genome Research
Verified
Journal Article
Open access
PDF file
LCLaure K. Case
Laure K. Case
EWEmma H. Wall
Emma H. Wall
JDJulie A. Dragon
Julie A. Dragon
NSNaresha Saligrama
Naresha Saligrama
DKDimitry N. Krementsov
Dimitry N. Krementsov
CTCory Teuscher
Cory Teuscher
Understanding the DNA elements that constitute and control the regulatory genome is critical for the appropriate therapeutic management of complex diseases. Here, using chromosome Y (ChrY) consomic mouse strains on the C57BL/6J (B6) background, we show that susceptibility to two diverse animal models of autoimmune disease, experimental allergic encephalomyelitis (EAE) and experimental myocarditis, correlates with the natural variation in copy number ofSlyandRbmymulticopy ChrY genes. On the B6 background, ChrY possesses gene regulatory properties that impact genome-wide gene expression in pathogenic CD4+T cells. Using a ChrY consomic strain on the SJL background, we discovered a preference for ChrY-mediated gene regulation in macrophages, the immune cell subset underlying the EAE sexual dimorphism in SJL mice, rather than CD4+T cells. Importantly, in both genetic backgrounds, an inverse correlation exists between the number ofSlyandRbmyChrY gene copies and the number of significantly up-regulated genes in immune cells, thereby supporting a link between copy number variation ofSlyandRbmywith the ChrY genetic element exerting regulatory properties. Additionally, we show that ChrY polymorphism can determine the sexual dimorphism in EAE and myocarditis. In humans, an analysis of the CD4+T cell transcriptome from male multiple sclerosis patients versus healthy controls provides further evidence for an evolutionarily conserved mechanism of gene regulation by ChrY. Thus, as inDrosophila, these data establish the mammalian ChrY as a member of the regulatory genome due to its ability to epigenetically regulate genome-wide gene expression in immune cells.